73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers review use of MRI to identify brain cancer biomarkers

Researchers review use of MRI to identify brain cancer biomarkers

byKing's College LondonCredit: Pixabay/CC0 Public DomainResearchers from the School of Biomedical Engineering & Imaging Sciences (BMEIS) have published asystematic reviewin&n

Researchers review use of MRI to identify brain cancer biomarkers

byKing's College LondonCredit: Pixabay/CC0 Public DomainResearchers from the School of Biomedical Engineering & Imaging Sciences (BMEIS) have published asystematic reviewin&n
GI symptoms persist in older female colorectal cancer survivors, study finds

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba
Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress
Study brings new understanding of multiple myeloma evolution

Study brings new understanding of multiple myeloma evolution

by University of Texas M. D. Anderson Cancer CenterGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.007A new study by researchers at The University of Texas

Study brings new understanding of multiple myeloma evolution

by University of Texas M. D. Anderson Cancer CenterGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.007A new study by researchers at The University of Texas
Combination treatment improves survival in advanced prostate cancer with genetic mutations

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant
Blocking proteins could pull the plug on power for colon tumors

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l
Researchers identify neutrophils as major culprits in treatment resistance of pancreatic cancer

Researchers identify neutrophils as major culprits in treatment resistance of pancreatic cancer

by Sylvester Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers have shown for the first time exactly how immature neutrophils—white blood cells that are an important part of the

Researchers identify neutrophils as major culprits in treatment resistance of pancreatic cancer

by Sylvester Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers have shown for the first time exactly how immature neutrophils—white blood cells that are an important part of the
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatmen

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatmen
Adhering to global health recommendations reduces cancer risk

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms
ASCT may offer alternative for therapy for high-risk follicular lymphoma

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin
New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th